A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
RIP Fleas, the environmental flea treatment from Genitrix, has been given a new formulation to ensure it acts more quickly in the killing of adult fleas and that it continues to kill fleas as they emerge from pupae for up to 12 months.
Now known as RIP Fleas Extra, the product is also licensed for the control of house dust mites in the environment for up to 12 months.
According to Genitrix, the reformulation makes RIP Fleas Extra the only environmental flea treatment to contain three active ingredients while complying fully with new EU Biocides regulations. It is the only such treatment to be fragranced and is also the only product to be presented in a volume which will cover 120 square metres - ie the size of an average house.
RIP Fleas Extra contains:
When used synergistically, Tetramethrin and Permethrin provide a rapid knockdown and kill of fleas as they hatch from pupae. Studies have shown that this combination works four times more quickly than Permethrin alone.
Dr Westwood, who now lives in Australia, had been referred to the Committee in relation to a number of charges against him relating to the treatment of a cat at his former practice in Cardiff in October 2015.
He was not present at the inquiry and had requested that his solicitor, Tony Wilson, act on his behalf.
Mr Wilson made an application to the Committee that the hearing should be adjourned contingent on a form of undertakings being accepted. These undertakings were that Dr Westwood’s name be removed from the Register with immediate effect and that he never apply to be restored to the Register under any category.
The application was granted by the Committee, taking into account a number of factors. These included the fact that Dr Westwood has retired as a veterinary surgeon, that he has closed his practice and returned to his home in Australia with no intention of returning to the UK, and that animal welfare and the reputation of the profession have been protected as Dr Westwood will no longer be in practice.
The Committee noted that there were several precedents for concluding cases in such a manner, and that the application was not objected to by the complainant or opposed by the College.
Dr Westwood’s name was removed from the Register of Veterinary Surgeons with immediate effect as of Monday 14 August 2017.
The Veterinary Benevolent Fund has launched a short film about a veterinary surgeon's experience of severe depression and her inspiring recovery.
The charity says it hopes the film, published on the Vetlife website today, will encourage the veterinary profession to talk more openly about stress and depression in the workplace and will motivate veterinary employers to adopt best practice in supporting their staff's mental health.
Nick Short, the VBF Director responsible for the development of the Vetlife website, said: "We are so grateful to the veterinary surgeon concerned for having the courage to share her story and for her insights into what could be done to make recovery easier for other vets. We were delighted to hear that she felt she was treated well and got the help she needed from the Veterinary Benevolent Fund and the Veterinary Surgeons' Health Support Programme.
"Recent press reports have estimated that the cost to the UK economy of stress, depression and suicide is £26 billion per year. We know that the profession has a high incidence of these problems, so it follows that depressive illness must have an alarming economic effect on it. This means it is essential to invest in improving awareness and support.
"The VBF wants to produce more web videos on issues that veterinary surgeons, students or nurses commonly encounter such as debt, addiction, professional conduct or employment problems. However, we need to secure additional sponsorship in order to fund this work - each 5 minute video will cost about £2,500 to produce. If you or your organization would be interested in supporting this work, please contact the VBF office at 7 Mansfield Street, London W1G 9NQ, telephone 020 7908 6385 or email info@vetlife.org.uk. Donations can also be made online at www.justgiving.com/VBF"
Rory O'Connor, National Co-ordinator at the Veterinary Surgeons' Health Support Programme said: "Many of us will have mental health problems at some point in our lives but most can make a full return to work with the right support. As highlighted in the film, it is really helpful if employers are willing to explore adjustments to working conditions or to the working environment such as flexible working hours or changes to working responsibilities. I am always available to help both employers and employees with these kinds of discussions and we are currently developing content on mental health support in the workplace for the Vetlife website. All advice is completely confidential."
The film was made by John Somers and Ben Sheriff at the University of Exeter using an actress to speak the words of the veterinary surgeon.
Vétoquinol - maker of Epiphen, the anti-epileptic phenobarbital for the control of epilepsy in dogs - has added a new client brochure and a fridge magnet to its Epiphen support packs, designed to help owners understand the condition and make it easier for them to comply with daily dosage requirements.
The new brochure is called What I need to know and is written for clients that have been prescribed Epiphen for their pet for the first time.
Abbie King, Product Manager for Epiphen, said: ''The inspiration for the new brochure came after spending time at the Animal Health Trust in Newmarket and realising how much information an owner needs to take in when their dog is diagnosed with epilepsy."
The new brochure covers the important information owners need to help them understand and manage their dog's epilepsy, including how Epiphen works, what they can do to help their dog, how to monitor seizures, where to find further information and frequently asked questions.
The Epiphen Treatment fridge magnet is designed as a quick reference guide to prescribing information that is needed every day when living with a dog with epilepsy. The magnet leaves space for the owner to write in their dog's name, dosage details and timings and their vet's phone number. Vétoquinol says it is especially helpful as a reference if more than one person is caring for the dog.
The new items enhance the existing Epiphen support pack, which comprises an owner manual, medication record and seizure diary, dog tags, seizure report pads, free serum level monitoring vouchers and a free, online resource at www.epiphenonline.co.uk
Vétoquinol also invites practitioners who are dealing with challenging cases to take advantage of its free Ask the expert scheme on 0800 169 8197 or email a case history to epiphen@vetoquinol.co.uk.
To order the new Epiphen support materials, ring 0800 1698197. Alternatively, visit: www.vetoquinol.co.uk to find out more.
Veterinary nurses, veterinary surgeons, students and other veterinary professionals are all invited to take part in the anonymous survey and share incidents where they have witnessed discrimination or felt discriminated against.
The survey covers the nine protected characteristics under the Equality Act: age, gender reassignment, marital or partnership status, being pregnant, disability, race, religion, sex and sexual orientation. It also includes other forms of discrimination which might not fit under these characteristics, such as body weight and socio-economic background.
BVA Junior Vice President Daniella Dos Santos said: "The veterinary professions should be open, welcoming and supportive of everyone; however, it is clear from the reports we’re hearing that discrimination is still an issue. Worse still, we’re aware that some colleagues have faced a backlash when talking about their experiences of discrimination. This is completely unacceptable.
"If we hope to prompt meaningful change we need to fully understand the scale of the problems our colleagues are facing. To do that it’s important that we provide a safe, anonymous space for everyone to share their experiences. We hope this questionnaire will give people that opportunity and we would like to sincerely thank our colleagues for their willingness to share their personal experiences with us."
The survey was developed with the support of the British Veterinary Ethnicity and Diversity Society (BVEDS) and British Veterinary LGBT+.
BVA says it intends to gather further quantitative data on discrimination via its Spring Voice of the Veterinary Profession Survey 2019.
The questionnaire is open from 2 February until 2 March and should take around 10 minutes to complete. A link to the questionnaire is available here.
Vets and vet nurses are being asked to take part in a survey which aims to help the industry get a better understanding of canine reproduction health issues.
The survey is being conducted by Virbac Animal Health as part of its reproductive health awareness campaign.
Product manager Chris Geddes MRCVS said: "Following a series of CPD seminars on reproduction, it is evident that the views and experiences of vets vary considerably when it comes to companion animal sexual health.
"The aim of the survey is to obtain a clearer picture of the thoughts and experiences of vets and VNs on the neutering of dogs in the UK. The questionnaire will help us gain a better understanding of practice needs in this often sensitive area, and help provide improved support for vets and pet owners alike.
"Whilst attitudes on neutering vary from country to another, it is clear that within the UK, opinion among vets and pet owners is wider than perhaps we currently realise. The UK currently has the highest canine male and female neutering rate in Europe. What this means will depend on your viewpoint and experiences, however we know that some practices are beginning to offer clients a wider range of options."
He added: "As a veterinary-focused business our aim is to provide solutions which will help support and develop the relationship between practice and client. This survey is part of that continuing process."
All those completing the questionnaire will receive a Cadbury's chocolate bar for taking part, with one lucky person winning £250.00 of M&S vouchers.
If you would like to take part please visit http://www.virbacsurvey.animaloracle.com/
Ceva Animal Health has announced the winners of it's firework waiting room display competition which, according to the company, had a record-breaking number of entries submitted this year.
To enter the competition, practices had to create an eye-catching display to help educate owners on firework fears in pets and how to prepare them for firework season with the help of pheromone products Feliway for cats and DAP for dogs. Ceva supplied entrants with marketing materials featuring Ceva's animated characters 'That Purple Cat' and 'Dap The Dog' from the company's TV advertising and marketing campaign.
South Beech Veterinary Surgery, Essex, Broadleys Veterinary Hospital, Stirling and The Avenue Veterinary Clinic in Ealing were the three winners, and each receive a pizza lunch for the whole practice to enjoy.
Rachel Levy, marketing support manager for Ceva said: "As always we received some fantastic entries and it was so hard to choose the winners. We would like to thank everyone who entered for their continued support and hard work in creating the displays.''
For further information on DAP and Feliway, visit www.secrettohappypets.com.
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Remote consultations and prescribing have been the subject of much debate in the profession of late. A motion to conduct a trial of prescribing without a physical examination was considered by the RCVS Council in November, when a large number of serious concerns were raised.
However, none of those concerns related to the provision of remote consulting services for existing clients with animals who are already under the care of the veterinary surgeon. That's where systems like this could add real value to the service offered by veterinary practices.
George Kyriacou, Director at VVG said: "Telemedicine is happening, and it’s happening in a big way. Virtual consultations are becoming more and more popular with pet owners who are not really sure if they need to see a vet and would simply like some reassurance.
"An option to have a qualified vet in your pocket at anytime of the day is attractive. However, the option to have a convenient consultation with your own trusted vet is the holy grail."
The system allows those practices who wish to charge for online consults to take payment online. Some, however, offer free consultations, in particular post-op, because it saves everyone time.
VVG points out that the system can also be used to deliver nursing consultations, too.
Simon Power, Commercial Manager at Vets One referrals in Crimplesham, Norfolk said: "Since adopting the system we have had a number of post-op and medication reviews virtually; it not only saves us a consulting room but also allows our clients to have the expert advice our team provide from the comfort of their own home."
VVG costs £249 to set up, plus from £59 per month thereafter, per practice.
For more information, contact George Kyriacou at George@thevvg.com or call 01842558022.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Medivet is celebrating its 100th batch collection for Vet Blood Supplies, the north London-based bloodbank set up in 2007 to provide blood products for its branches around the country.
Veterinary nurse Laura Brind, who is responsible for collecting the blood, said: "We are really proud to celebrate the 100th collection. We travel to Retired Greyhound Trust kennels across south-east England who kindly agreed to arrange the donation in return for free preventative treatment for the dogs."
The collection was taken from Barn Kennels, the Portsmouth branch of the Retired Greyhound Trust, which has been donating blood for the past 18 months.
Novartis Animal Health's year long campaign to drive pet-owner awareness of the importance of worming pets regularly got off to a rather damp start in London today, with 63 people in doggy suits - mostly company employees I gather - running around the capital accompanied by two 'pooch vans'.
The 'Worm Patrol' team will be visiting veterinary practices over the summer to help promote, set up and run Pet Worming Awareness Days and attend practice open days. Veterinary practitioners will have access to the Worm Patrol support kit including the branded pooch van, Chewy the dog mascot and a worm patrol ambassador. Additional support will include educational leaflets for owners, giveaways and waiting room materials.
Maggie Fisher, Chairperson of the European Scientific Counsel for Companion Animal Parasites is backing the campaign. She said: "Raising awareness of worm control throughout the life of cats and dogs is important, particularly when it is reported that 80 percent of children kiss their pet and 21 percent let them lick their fingers after sharing food. While the risk may be relatively low, the consequences can be serious, especially in children.
"It's important that pet owners take responsibility for their animals and we are pleased that initiatives such as the Worm Patrol and 'Pet Worming Awareness Days' will help practices highlight the risk that endoparasites pose to humans and companion animals in a novel and light-hearted way."
To arrange for the Worm Patrol to visit to your practice, or for further information about setting up a Pet Awareness Worming Day, please contact your Novartis Animal Health Territory Manager or Novartis Animal Health UK Ltd on +44 (0)1276 694402.
The BVA has responded to the Written Ministerial Statement from the Defra Secretary of State at the end of the licence for badger culling in Somerset.
BVA President Robin Hargreaves said: "The British Veterinary Association (BVA) has supported the pilot culls in England to determine whether badger culling can be delivered humanely, effectively, and safely by controlled shooting.
"We will not prejudge the report of the Independent Expert Panel (IEP), which will consider data from the initial 6-week pilots in Somerset and Gloucestershire, but we are interested to note the Secretary of State's announcement that current indications suggest that the pilot has been safe and humane.
"Today our Veterinary Policy Group has discussed the issues surrounding the extensions to the licences. We agree with the Chief Veterinary Officer's advice that extensions in order to remove a greater number of badgers and get closer to achieving the 70% rate of the Randomised Badger Culling Trials (RBCTs) are justified to improve the bovine TB disease situation and mitigate the potential impact of badger perturbation.
"Following questions raised by our members we have been assured by Defra that monitoring of the culling will continue to ensure it is being carried out in accordance with the humaneness and safety stipulations in the licences. Although it is important to note that this data will not form part of the information being considered by the IEP.
"We await the report of the IEP and will engage members in considering what impact it will have on the overall bovine TB eradication strategy for England."
According to the AHT, there is undisputed evidence that owners, riders and trainers have a poor ability to recognise signs of pain seen when horses are ridden. As a result, problems are labelled as training-related, rider-related, behavioural, or deemed 'normal' for that horse because 'that’s how he’s always gone'.
This, says the AHT, means pain-related problems are often disregarded, the horse continues in work, and the problem gets progressively worse.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, believes it may be easier to educate riders and trainers to recognise changes in facial expression and behaviour rather than lameness. So she and her team set out to develop and test an ethogram to describe facial expressions in ridden horses and to determine whether individuals could interpret and correctly apply the ethogram consistently.
At this stage in the project, they concluded that their ethogram could reliably be used to describe facial expressions of ridden horses by people from different professional backgrounds (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(16)30184-8/fulltext).
In the next stage of the project, Sue and her team sought to demonstrate that the ethogram could be used to identify lameness.
The ethogram was applied blindly by a trained analyst to photographs (n=519) of the head and neck of lame (n=76) and non-lame (n=25) horses acquired during ridden schooling-type work at both trot and canter. These included images of seven lame horses acquired before (n=30 photographs) and after diagnostic analgesia had abolished lameness (n=22 photographs).
A pain score (0-3; 0=normal, 1-3=abnormal) was applied to each feature in the ethogram, based on published descriptions of pain in horses.
A total of 27,407 facial markers were recorded, with those giving the greatest significant difference between lame and sound horses including ears back, eyes partially or fully closed, an open mouth with exposed teeth and being severely above the bit.
Pain scores were higher for lame horses than non-lame horses (p<0.001). Total pain score (p<0.05), total head position score (p<0.01), and total ear score (p<0.01) were reduced in lame horses after abolition of lameness.
Severely ‘above the bit’, twisting the head, asymmetrical position of the bit, ear position (both ears backwards, one ear backwards and one to the side, one ear backwards and one ear forwards) and eye features (exposure of the sclera, the eye partially or completely closed, muscle tension caudal to the eye, an intense stare) were the best indicators of pain.
The researchers concluded that application of the ethogram and pain score could differentiate between lame and non-lame horses. Assessment of facial expression could potentially improve recognition of pain-related gait abnormalities in ridden horses (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(17)30019-9/fulltext)
Sue and her team are now working on the development of a whole horse ethogram and its application to non-lame and lame horses, to help to differentiate between manifestations of conflict behaviour, in response to the demands of the rider, and pain. They are also working towards the development of a practical tool for recognising facial expressions, similar to that of a body condition score chart, which they say could dramatically improve the health and welfare of all horses.
Photo: Signs of pain include ears back (pain score of 3), intense stare, muscle tension and mouth. Courtesy Dr Sue Tyson.
A group of brave veterinary nurses and a student nurse leapt out of a perfectly serviceable aircraft last weekend, both to raise money for children with epilepsy, and to highlight the need to protect the title 'Veterinary Nurse' in law.
Vicky Couzens, Jenny Cook, Kim Blowing, Michelle Dickens, Gillian James and Leigh Martin, none of whom had parachuted before (in fact, Gillian hadn't even been in a plane before), were raising money for the Muir Maxwell Trust, a charity which funds research into childhood epilepsy, and supports the families of some of the 70,000 children affected by it in the UK.
The daredevil nurses also wanted to highlight the fact that anyone can call themselves a veterinary nurse, regardless of whether they've ever even set foot inside a veterinary practice, let alone passed the demanding examinations. They argue that the title 'Veterinary Nurse' should be protected in law, in exactly the same way as 'Veterinary Surgeon', so that the pet-owning public can have the reassurance of knowing when their animal is being cared for by a qualified professional.
To support these nurses' efforts, and help them reach their fundraising targets, click the links below:
http://www.justgiving.com/Victoria-Couzens http://www.justgiving.com/Jenny-Cook23 http://www.justgiving.com/KimBlowing http://www.justgiving.com/Michelle-Dickens
Meanwhile, one of the children that has benefitted from the work done by the Muir Maxwell Trust is Emily Guthrie, daughter of the editor of VetNurse.co.uk and VetSurgeon.org. She sent the jumpers her own message of thanks:
watch?v=jI90GdmIUGk
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
Zea Sciences has announced that its natural rodenticide has been certified under the European Biocide Directive Program, known as Annex1/1A BPD 98/8EEC.
The rodenticide is made from powdered corn cob (PCC) which, according to Zea Sciences, causes rats and mice to die of hypovolemic shock within 4-7 days of starting to feed on it.
The company says PCC poses no health risk to human or non target animal species, such as cats, dogs and birds. It is also the first of its type and class to be officially acknowledged as using naturally biodegradable and environmentally friendly material.
PCC is available from a number of retail and trade outlets, under various different brand names. However, the company said that if there was sufficient interest by vets in stocking the pet-friendly product, it would look at making it available through veterinary wholesalers.
Martin Holland, Managing Director of Zea Sciences said: ''I hope the profession will help spread the word about PCC-based rodent control - it might mean you have to reach for the vitamin K a little less often."
Ella, a Bloodhound Doberman cross, is the first cold scent dog to work with anti-poaching units in the Eastern Cape of South Africa.
She has been trained specifically to work on crime scenes which are more than a day old and can follow poachers’ tracks to determine their entry and exit points to reserves, as well as their shooting positions.
Medivet says that during her first year, none of the reserves where Ella has been active have lost a single rhino. A number of court cases are also ongoing in other reserves as a result of evidence she has uncovered at crime scenes.
The cost of training Ella, her handler, support vehicle and accommodation has all been funded by the Medivet Rhino programme and by the generous donations of Medivet clients, through the Pennies digital charity box scheme.
To date, Medivet Rhino has raised more than £315,000 via Pennies to help fund this rhino protection programme.
Dr William Fowlds from the Wilderness Foundation Africa (and former Medivet employee) said: "As a cold scent tracking dog, Ella brings a formidable skill set to our anti-poaching units. Her ability to track human footsteps across a variety of terrains, day or night, is a significant deterrent to those thinking of killing our rhinos. In addition, her gentle nature makes her an endearing member of the team so, even though she’s a working dog, we can sneak a little cuddle in every now and again."
He added: "Ella is a game changer in our efforts to protect rhinos. The difference she has made to our work in just one year means that we are now working with our partner, the Chipembere Rhino Foundation, to extend our canine resources. We are indebted to Medivet and its clients for supporting our work by giving us this wonderful dog."
Dr John Smithers, Senior Partner and Project Co-ordinator for Medivet Saving the Rhino, said: "We could not be prouder of Ella’s work to track poachers during her first year in the Eastern Cape of South Africa.
"With her incredible sense of smell, she has brought a new dimension to rhino protection in this region, and all of the agencies involved in protecting this iconic species benefit from her presence.
"We are deeply grateful to all our clients and staff who have supported Medivet Saving the Rhino (through Pennies and other donations) and wish Ella and her support team another successful year ahead."
The Animal Medicines Training Regulatory Authority (AMTRA) is launching its new Continuous Professional Development (CPD) scheme today, designed to ensure that the Authority's registered Suitably Qualified Persons (SQPs) keep up to date with the latest animal medicines information.
In order to maintain their SQP status, every SQP will have to achieve a minimum number of CPD points during each AMTRA CPD period, running for two years from July to June. However, in the initial stages of the scheme, this first period will run for 33 months, from October 2008 to June 2011, allowing AMTRA to fine tune the system if required and give its SQPs time to get used to the new structure.
During these CPD periods, SQPs are required to obtain a minimum number of CPD points depending on their SQP type:
SQP Type: Modules; VPS medicines supplied; CPD Points R-SQP: FAM+EQM+CAM; All VPS Medicines; 70 points G-SQP: FAM+EQM; VPS-farm animals and equines only; 50 points K-SQP: FAM+CAM; VPS-farm and companion animals only; 50 points E-SQP: EQM+CAM; VPS-equines and companion animals only; 50 points L-SQP: FAM; VPS-farm animals only; 30 points J-SQP: EQM; VPS-equines only; 30 points C-SQP: CAM; VPS-companion animals only; 30 points
(FAM - Farm Animal Module, EQM - Equine Module, CAM - Companion Animal Module)
In essence, this means that 20 points are required per animal group, plus a further 10 points. Dr Roger Dawson, Secretary of AMTRA comments, "There is no maximum number of CPD points that SQPs can accumulate and we will be encouraging them to gain the benefit of as much CPD as they can."
Those SQPs who do not achieve the minimum number of CPD points by the end of the period will not be eligible to renew their status for the following year. However, such SQPs will have the option of sitting an examination before the end of that CPD period in order to maintain their SQP status and eligible be to renew for the next year.
SQPs will have a range of avenues through which to gain CPD points, ranging from four types of AMTRA-accredited CPD Events, to online study and personal study. With CPD Events and online studies, accreditation and points will be awarded by the AMTRA CPD Accreditation Panel. With personal study, AMTRA accepts a degree of self-certification of this form of CPD, however the points gained in this way are limited to a relatively small proportion of the minimum required in a CPD period.
Throughout a CPD period, all SQPs are required to attend at least ONE CPD Event. These events will comprise a range of modules that will be assessed for coverage, of relevant topics ranging from legislation, regulations and prevalence & effects of parasites and pathogens, to control of disease management, resistance, warnings and SARS.
Dr Dawson says, "The new CPD scheme has the necessary flexibility to allow SQPs to gain the required CPD points via a number of routes, from accredited CPD events and online study to personal study. Furthermore, the structure of the scheme ensures that their studies will be properly assessed to ensure they have gained the necessary knowledge to secure their CPD points."
Genitrix has announced the reformulation of Cerusolve, which cleans and deodorises the external ear canal of cats and dogs.
According to the company, the reformulation has enhanced Cerusolve's exfoliant and keratolyic properties and has given it a new fresh fragrance. Cerusolve ingredients now include:
Cerusolve is presented in a 100 ml bottle with a soft canula for application. It is priced at £5.65.
Genitrix Marketing Director Rob Watkins said: "Cerusolve has proved itself in practice as a gentle but effective ear cleaner in dogs and cats. The reformulation has given us the opportunity to increase the acidity of the product following a recent study which suggested that topical acidifying products could be therapeutically beneficial for cutaneous yeast infections.
"We believe the new ingredients will enhance the product and, to celebrate its arrival, we're offering practices the opportunity to buy five bottles of Cerusolve and get one free."
Further details are available from Genitrix on 01403 786345.
Mr Wood was convicted of three offences which involved the download of 38 videos and 13 indecent images of children, at Portsmouth Magistrates’ Court in December 2017.
In January 2018, he was sentenced to a three-year Community Sentence for each offence, to run concurrently, and was made subject to a five-year Sexual Harm Prevention Order.
He was also fined £1,000 and ordered to pay costs of £340 and a victim surcharge of £85.
Mr Wood was also placed on the barring list by the Disclosure and Barring Service and required to register with the police pursuant to the Sexual Offences Act 2003 for a period of five years.
Mr Wood appeared before the Disciplinary Committee, admitted his conviction and accepted that it rendered him unfit to practise veterinary surgery.
In determining the sanction, the Committee says it took into account a number of mitigating factors: his conviction involved no actual harm or risk of harm to an animal; there was no financial gain; he had engaged in open and frank admissions at an early stage; he was experiencing mental ill-health at the time of the offence; he had taken subsequent steps to avoid a repetition of such behaviour; there had been a significant lapse of time since the incident; and he showed insight into the harm caused by his offence.
The Committee also considered that the purpose of a sanction is not to punish, but to protect the welfare of animals, as well as maintain public confidence in the profession and declare and uphold proper standards of conduct. On consideration of the appropriate sanction, the Committee decided that postponement of judgement was not appropriate, and that taking no action was not an option.
The Committee then considered whether a reprimand or warning was appropriate, but they considered that would not match the gravity of the offence – a period of suspension would also mean Mr Wood would automatically return to the Register after the period of time without the College being able to review his fitness to practise, rendering it an inappropriate sanction. The Committee therefore determined that the removal of Mr Wood from the RCVS Register was the only way to protect the wider public interest and maintain confidence in the profession.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has not taken this decision lightly, and, lest it be misinterpreted, it has not taken it in order to satisfy any notional public demand for blame and punishment.
"It has taken the decision because in its perception, the reputation of the profession had to be at the forefront of its thinking and ultimately it was more important than the interests of the Respondent.
"The decision is not simply based on the fact that these offences were of a sexual nature but because they were repeated frequently over a significant period of time, and at the time, the Respondent knew on his own admission that what he was doing was wrong.
"Accordingly, the Committee had decided that removal from the Register is appropriate and proportionate in this case. The Committee will direct the Registrar to remove the Respondent’s name from the Register forthwith."
Mr Wood has 28 days to appeal the Committee’s decision after which, if no appeal is received, the Committee’s judgment takes effect.
VetNurse Reactions now gives members a quick and easy way to say 'thank you' for sharing something in the forums or the photo/video galleries, and, in the future, for VetNurse.co.uk to reward those members whose contributions are most appreciated by the community.
In addition to saying 'thank you', members can also say they 'agree' or 'disagree' with the content of a post, a far more precise expression than the previous rating system, in which 'one star' which could be interpreted as meaning almost anything.
VetNurse Reactions also give you a quick and easy measure of how much a contributor has been thanked, agreed with or disagreed with by other members.
With a number of new features introduced over the last year, VetNurse.co.uk now offers far more compelling reasons to hold clinical discussions in its forums, rather than other other social media platforms:
VetNurse Profiles are visible to all logged in members, so you can see the professional credentials of the person who posted advice or opinion.
VetNurse 'Claim CPD' allows you to record time spent in clinical discussions, and claim a downloadable VetNurse CPD certificate towards your annual CPD requirement.
VetNurse forum discussions are far, far easier to follow and refer back to than Facebook discussion threads, which are more transient in nature.
VetNurse.co.uk Editor Arlo Guthrie added: "As for 'thank you', I don’t know why I didn’t think of it years ago. 'Thank you' is something missing from almost every other social media platform I’ve ever seen, and yet it’s SUCH an important courtesy.
"So, remember, if you see something on VetNurse posted by another member which you found helpful, don’t forget to hit the 'thank you' button. If they’ve had one of those days when every client seems utterly thankless, some appreciation from their peers might make a lousy day bearable."
Defra has confirmed that equine infectious anaemia (EIA) has been detected in two horses in Wiltshire following importation from Romania via Belgium.
The premises is currently under restriction and the two infected horses will be humanely destroyed in line with existing regulations. The other horses on the premises will be subject to epidemiological investigation in the coming weeks. A further two horses have also been under investigation and test results have proved negative.
The animals arrived in a group of 10 horses, nine of which originated from Romania and one from Belgium. The nine Romanian horses were tested for EIA as part of routine post-import testing. Seven horses all tested negative. The horse that originated in Belgium is due to be tested shortly.
Chief Veterinary Officer, Nigel Gibbens said: "This is the first case of equine infectious anaemia infected animals being imported into Great Britain since 1976 and shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy these two horses that tested positive."